Cadrenal Therapeutics Shares Are Trading Higher After the Company Received FDA Orphan Drug Designation for Tecarfarin for the Prevention of Thromboembolism and Thrombosis in Patients With an Implanted Mechanical Circulatory Support Device
Cadrenal Therapeutics的股价走高，此前该公司获得美国食品药品管理局的替卡法林孤儿药认定，用于预防植入机械循环支持装置患者的血栓栓塞和血栓形成